SCHEMBL5843853

SCHEMBL5843853

Nc1ccc(-c2cc(Cl)ccc2Cl)cc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.55
HSD17B10 Q99714 4/20 0.55
ALOX15 P16050 3/20 0.55
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPK1 P28482 2/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47
TSHR P16473 6/20 0.45
TDP1 Q9NUW8 2/20 0.45
TP53 P04637 2/20 0.45
HTR2B P41595 1/20 0.43
PDE4D Q08499 1/20 0.43
ESR2 Q92731 1/20 0.42
ALOX5 P09917 1/20 0.41
RECQL P46063 1/20 0.40
IDO1 P14902 1/20 0.39
CNR2 P34972 2/20 0.39
AHR P35869 1/20 0.38
CA12 O43570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5845267 0.86 HSD17B10 (0.55) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2
SCHEMBL5843433 0.85 CYP3A4 (0.40) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2
SCHEMBL5843930 0.84 ALOX15 (0.53) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2
SCHEMBL5843155 0.83 ALOX15 (0.52) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2
SCHEMBL5843781 0.83 CYP3A4 (0.52) CYP3A4HSD17B10ALOX15ALDH1A1MAPK1
SCHEMBL5845543 0.83 CYP3A4 (0.52) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2
SCHEMBL5842547 0.80 CYP3A4 (0.57) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2
SCHEMBL5845307 0.79 ALOX15 (0.52) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2
SCHEMBL5845314 0.79 CYP3A4 (0.52) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2
SCHEMBL5845318 0.79 ALOX15 (0.74) CYP3A4HSD17B10ALOX15ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US claimed
EP-1562539-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES Wella Aktiengesellschaft (DE) 2005-08-17 EP claimed
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-07-21 US claimed
WO-2004041226-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2004-05-21 WO claimed
EP-1562539-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES Wella Aktiengesellschaft (DE) 2005-08-17 EP disclosed
WO-2004041226-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2004-05-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives KRT18, CBR3, CCNB3 CYP3A4 835/4885HSD17B10 913/4885ALOX15 3006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.